FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure
PARSIPPANY, N.J., July 26 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide), a new three-in-one combination product...
Short URL: http://drugrehab.in/?p=65787
Posted by admin
on Jul 26 2010. Filed under New Drug Approvals.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.
